{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:04:56Z","timestamp":1775300696064,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1124\/jpet.112.201970","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T05:15:24Z","timestamp":1359090924000},"page":"85-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Positional Isomers of Aspirin Are Equally Potent in Inhibiting Colon Cancer Cell Growth: Differences in Mode of Cyclooxygenase Inhibition"],"prefix":"10.1016","volume":"345","author":[{"given":"Ravinder","family":"Kodela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitali","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satindra","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zong Yuan","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen P.N.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran V.","family":"Nia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Vel\u00e1zquez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khosrow","family":"Kashfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.201970_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/bega.2001.0230","article-title":"Epidemiology of NSAID-related gastroduodenal mucosal injury","volume":"15","author":"Aalykke","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1124\/jpet.112.201970_bib2","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1124\/jpet.112.201970_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-010-1074-x","article-title":"Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study","volume":"126","author":"Bardia","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1124\/jpet.112.201970_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1476-5381.1984.tb16447.x","article-title":"The anti-ulcerogenic activity of the unripe plantain banana (Musa species)","volume":"82","author":"Best","year":"1984","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.112.201970_bib5","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa067208","article-title":"Aspirin and the risk of colorectal cancer in relation to the expression of COX-2","volume":"356","author":"Chan","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.112.201970_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1124\/jpet.110.171017","article-title":"Comparison between 3-nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugs","volume":"335","author":"Chattopadhyay","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.201970_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jnci\/djn485","article-title":"Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials","volume":"101","author":"Cole","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/jpet.112.201970_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14320","article-title":"Chemoprevention of colorectal cancer: systematic review and economic evaluation","volume":"14","author":"Cooper","year":"2010","journal-title":"Health Technol Assess"},{"issue":"Suppl 2","key":"10.1124\/jpet.112.201970_bib9","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S1590-8658(03)00047-1","article-title":"NO-aspirin: mechanism of action and gastrointestinal safety","volume":"35","author":"Fiorucci","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1124\/jpet.112.201970_bib10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1463-1318.2008.01746.x","article-title":"The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials","volume":"11","author":"Gao","year":"2009","journal-title":"Colorectal Dis"},{"key":"10.1124\/jpet.112.201970_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jnci\/djn484","article-title":"Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study","volume":"101","author":"Grau","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/jpet.112.201970_bib12","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djj206","article-title":"Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors","volume":"98","author":"Gr\u00f6sch","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/jpet.112.201970_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/1-4020-5688-5_4","article-title":"Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer","volume":"42","author":"Harris","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1124\/jpet.112.201970_bib14","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","article-title":"Aspirin intake and survival after breast cancer","volume":"28","author":"Holmes","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1124\/jpet.112.201970_bib15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1042\/BST0330724","article-title":"Is COX-2 a \u2018collateral\u2019 target in cancer prevention?","volume":"33","author":"Kashfi","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.1124\/jpet.112.201970_bib16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.bcp.2005.05.004","article-title":"Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention","volume":"70","author":"Kashfi","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.112.201970_bib17","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1124\/jpet.102.042754","article-title":"Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect","volume":"303","author":"Kashfi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.201970_bib18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bjp.0707176","article-title":"Surface phospholipids in gastric injury and protection when a selective cyclooxygenase-2 inhibitor (Coxib) is used in combination with aspirin","volume":"150","author":"Lichtenberger","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.112.201970_bib19","first-page":"G337","article-title":"Endogenous gastric mucosal prostaglandins: their role in mucosal integrity","volume":"242","author":"Ligumsky","year":"1982","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.112.201970_bib20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1245\/s10434-009-0382-z","article-title":"A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia","volume":"16","author":"Liu","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1124\/jpet.112.201970_bib21","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.91.8.3228","article-title":"Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic","volume":"91","author":"Masferrer","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.112.201970_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/gut.2009.190827","article-title":"Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?","volume":"59","author":"Pandeya","year":"2010","journal-title":"Gut"},{"key":"10.1124\/jpet.112.201970_bib23","first-page":"229","article-title":"Mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal injury and repair: a window of opportunity for cyclooxygenase-inhibiting nitric oxide donors","volume":"18","author":"Perini","year":"2004","journal-title":"Can J Gastroenterol"},{"key":"10.1124\/jpet.112.201970_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0005-2760(95)00100-Q","article-title":"Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo","volume":"1258","author":"Qiao","year":"1995","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl","key":"10.1124\/jpet.112.201970_bib25","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","article-title":"Cyclooxygenases: structural and functional insights","volume":"50","author":"Rouzer","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.112.201970_bib26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5694\/j.1326-5377.2006.tb00665.x","article-title":"Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review","volume":"185","author":"Schaffer","year":"2006","journal-title":"Med J Aust"},{"key":"10.1124\/jpet.112.201970_bib27","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0140-6736(07)60722-3","article-title":"Summing the risk of NSAID therapy","volume":"369","author":"Scheiman","year":"2007","journal-title":"Lancet"},{"key":"10.1124\/jpet.112.201970_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1100\/tsw.2002.81","article-title":"Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins","volume":"2","author":"Serhan","year":"2002","journal-title":"Scientific World J"},{"key":"10.1124\/jpet.112.201970_bib29","first-page":"362","article-title":"Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells","volume":"58","author":"Sheng","year":"1998","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.112.201970_bib30","first-page":"18","article-title":"Epidemiology of NSAID induced gastrointestinal complications","volume":"56","author":"Singh","year":"1999","journal-title":"J Rheumatol Suppl"},{"key":"10.1124\/jpet.112.201970_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/jpet.112.201970_bib32","first-page":"119","article-title":"The epidemiology of nonsteroidal anti-inflammatory drugs","volume":"13","author":"Tenenbaum","year":"1999","journal-title":"Can J Gastroenterol"},{"key":"10.1124\/jpet.112.201970_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1158\/1055-9965.EPI-07-0517","article-title":"Regular adult aspirin use decreases the risk of non-small cell lung cancer among women","volume":"17","author":"Van Dyke","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1124\/jpet.112.201970_bib34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1124\/jpet.112.201970_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.112.201970_bib36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.gastro.2003.10.063","article-title":"Cyclooxygenase-2 inhibitor (SC-236) suppresses activator protein-1 through c-Jun NH2-terminal kinase","volume":"126","author":"Wong","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.112.201970_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00018-007-7449-4","article-title":"Aspirin: recent developments","volume":"65","author":"Yasuda","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/jpet.112.201970_bib38","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1185\/03007990903212682","article-title":"Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs","volume":"25","author":"Yeomans","year":"2009","journal-title":"Curr Med Res Opin"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.201970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:20:24Z","timestamp":1739985624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524185618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0022356524185618"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.201970","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positional Isomers of Aspirin Are Equally Potent in Inhibiting Colon Cancer Cell Growth: Differences in Mode of Cyclooxygenase Inhibition","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.201970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}